The FDA has announced a major initiative to reduce nicotine levels in cigarettes and other tobacco products, aiming to make them nonaddictive. This proposal, initially floated during the Trump administration, has gained traction under the Biden administration as part of a broader strategy to combat smoking. Critics argue that this last-minute move may have unintended consequences, potentially benefiting illegal markets and impacting jobs. Experts are available to discuss the potential economic implications of these changes, while the ongoing debate continues regarding the effectiveness and feasibility of such regulations.